Welcome to our dedicated page for Arkema news (Ticker: ARKAY), a resource for investors and traders seeking the latest updates and insights on Arkema stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Arkema's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Arkema's position in the market.
On July 31, 2022, Arkema reported its total number of shares and voting rights. The company had 74,286,041 total shares and 86,577,526 voting rights, including shares held by the company. Excluding shares held by the company, the voting rights totaled 86,260,531. This data reflects Arkema's stock structure and is relevant for investors tracking stock performance and governance rights.
Arkema has disclosed its share buyback activities conducted between August 15 and August 19, 2022, in compliance with EU regulations. A total of 21,414 shares were repurchased at an average price of 89.2330 EUR. The transactions are aimed at enhancing shareholder value and optimizing the company's capital structure. This buyback activity underscores Arkema's commitment to return value to its investors.
Arkema has completed share buyback transactions from August 8 to August 12, 2022, in compliance with EU regulations. On August 10, 2022, the company bought back a total of 449 shares at a weighted average price of €89.78. The transactions reflect Arkema's commitment to returning value to shareholders through strategic financial activities.
Arkema reported a strong Q2 2022 with sales reaching €3.2 billion, up 32.9% year-over-year. EBITDA surged by 47.5% to €705 million, achieving a record margin of 22.1%. Specialty Materials, a key focus area, saw EBITDA grow by 41.8% to €600 million. Adjusted net income rose 65.9% to €443 million (€5.99 per share). Despite a slight decline in volumes, particularly in Europe, the company has raised its annual EBITDA growth guidance to 17%-22% due to strategic initiatives and successful acquisitions. Net debt increased to €2.79 billion but remains manageable, at 1.3x EBITDA.
Arkema plans to acquire Polimeros Especiales, a prominent Mexican producer of waterborne acrylic resins, reinforcing its position in the fast-growing market. Polimeros Especiales generated approximately US$40 million in sales in 2021 and employs 230 people. This acquisition aligns with Arkema's strategy to expand its Coating Solutions segment while promoting low-volatile organic compound solutions. The transaction is subject to regulatory approval and is anticipated to close in Q3 2022, aiding Arkema's growth in sustainable materials.
Arkema has announced its commitment to reduce greenhouse gas emissions by 46% by 2030, based on 2019 levels, aligning with the Paris Agreement's 1.5°C target. This ambitious plan includes both scope 1 and 2 emissions, aiming to limit them to 2 million tons of CO2 equivalent. Investments in decarbonization may reach €400 million. The company will focus on energy efficiency and renewable energy sources, while engaging suppliers to lower emissions across the value chain. Arkema aims to become a pure player in Specialty Materials by 2024, supporting sustainable development through innovative solutions.
On July 1, 2022, Arkema finalized the acquisition of Permoseal in South Africa, enhancing its adhesive solutions portfolio for DIY, packaging, and construction markets. Permoseal generated sales of €43 million in 2021 and operates two production plants. This strategic move aims to solidify Arkema's position in the growing South African construction market and expand its sustainable solutions. The acquisition aligns with Arkema's goal to become a pure Specialty Materials player by 2024, building on its 2021 sales of around €9.5 billion.
Arkema has released its voting rights report as of June 30, 2022. The total number of shares stands at 74,286,041, with total voting rights including company-held shares at 86,577,109. Excluding shares held by the company, the voting rights total 86,260,114. This data is vital for shareholders to understand their voting power in upcoming company decisions and reflects the current equity structure.
Emmanuelle Bromet has been appointed as the Sustainable Development Vice President at Arkema, effective July 28, 2022. Her role centers on steering Arkema's offerings towards environmentally friendly solutions and addressing circular economy and climate change initiatives.
Arkema aims to become a pure player in Specialty Materials by 2024, with reported sales of around €9.5 billion in 2021. The company operates in 55 countries with about 20,200 employees.
Arkema (Euronext: AKE) released a regulatory update detailing share metrics as of May 31, 2022. The total number of shares reached 74,286,041. Voting rights totaled 86,579,615, including shares held by the company, and 86,262,620 voting rights were noted when excluding company-held shares. These figures provide insights into the capital structure and governance mechanism of Arkema.